Opinion

Video

IPF and PDE4B Inhibitors

Dr Nathan highlights the role of PDE4B inhibitors in IPF management.

Video content above is prompted by the following:

  • What is the rationale for studying the phosphodiesterase 4 (PDE4) inhibitor pathway in idiopathic pulmonary fibrosis (IPF)?
  • How do PDE4 inhibitors differ from PDE4B inhibitors?
  • Why is this pathway of interest to pulmonologists and patients living with IPF?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
5 experts are featured in this series
2 experts in this video
5 experts are featured in this series
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo